Back to today’s briefing

Story perspectives

Study Shows Ozempic Cuts Alcohol Cravings by 30%

2/13/2025

34 5

Summary

Story summary

A groundbreaking study from the University of Southern California reveals that low-dose semaglutide, commonly known as Ozempic, can dramatically curb alcohol cravings and consumption. In a trial with 48 adults battling alcohol use disorder, those taking semaglutide reduced their drinking by nearly 30%. Researchers are eager to conduct further trials to validate these hopeful findings in the fight against alcohol addiction.

1 of 1

Story summary

A groundbreaking study from the University of Southern California reveals that low-dose semaglutide, commonly known as Ozempic, can dramatically curb alcohol cravings and consumption. In a trial with 48 adults battling alcohol use disorder, those taking semaglutide reduced their drinking by nearly 30%. Researchers are eager to conduct further trials to validate these hopeful findings in the fight against alcohol addiction.